Behçet's Disease from Rheumatology and Neurology Perspectives with Special Reference to Children

Abstract

Behçet's disease (BD) is an idiopathic chronic relapsing multisystemic vascular inflammatory disease. Although it is generally seen in young adults with male predominance, the onset age of the disease is the pediatric age group in only 4 to 26% of all cases of BD. According to the International Study Group for Behçet's Disease Classification Criteria, a diagnosis of BD requires recurrent oral aphthous ulcerations with two of the following: genital ulcerations, skin lesions, eye lesions, or a positive pathergy test. In this article, we extensively reviewed the current literature with respect to the rheumatological and neurological findings of BD in childhood.

Keywords

Behçet's Disease - neuro-Behçet - neurology - rheumatology

• References

• 1 Saylan T. Life story of Dr. Hulusi Behçet. Yonsei Med J 1997; 38 (06) 327-332
• 2 UStün C. A famous Turkish dermatologist, Dr. Hulusi Behçet. Eur J Dermatol 2002; 12 (05) 469-470
• 3 Turgut YB, Turgut M. Turkish scientist Hulusi Behçet (1889-1948) and his contribution to the medical world. Childs Nerv Syst 2019;
• 4 Yemni O. Ord. Prof. Dr. Hulusi Behçet. Deri Hast Frengi Arş 1964; 1: 58-59
• 5 Behcet H. Uber rezidivierende, aphthose, dürchein Virus verursachte Geshwure am Munde, am Auge und an den Genitalien. Dermatol Wochenschr 1937; 36: 1152-1157
• 6 Caruso P, Moretti R. Focus on neuro-Behçet's disease: a review. Neurol India 2018; 66 (06) 1619-1628
• 7 Jennette JC, Falk RJ, Bacon PA. , et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65 (01) 1-11
• 8 Hatemi G, Christensen R, Bang D. , et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis 2018; 77 (06) 808-818
• 9 International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335 (8697): 1078-1080
• 10 International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014; 28 (03) 338-347
• 11 Koné-Paut I. Behçet's disease in children, an overview. Pediatr Rheumatol Online J 2016; 14 (01) 10
• 12 Koné-Paut I, Shahram F, Darce-Bello M. , et al; PEDBD group. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 2016; 75 (06) 958-964
• 13 Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S. The performance of different classification criteria in paediatric Behçet's disease. Clin Exp Rheumatol 2017; 35 (6, Suppl 108): 119-123
• 14 Uluduz D, Kürtüncü M, Yapıcı Z. , et al. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology 2011; 77 (21) 1900-1905
• 15 Zouboulis CC, Kötter I, Djawari D. , et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 1997; 38 (06) 411-422
• 16 Koné-Paut I, Yurdakul S, Bahabri SA. , et al. Clinical features of Behçet's disease in children: an International Collaborative Study of 86 cases. J Pediatr 1998; 132 (04) 721-725
• 17 Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Paediatric Behçet's disease: a UK tertiary centre experience. Clin Rheumatol 2016; 35 (10) 2509-2516
• 18 Koné-Paut I, Darce-Bello M, Shahram F. , et al; PED-BD International Expert Committee. Registries in rheumatological and musculoskeletal conditions. Paediatric Behçet's disease: an International Cohort Study of 110 patients. One-year follow-up data. Rheumatology (Oxford) 2011; 50 (01) 184-188
• 19 Atmaca L, Boyvat A, Yalçındağ FN, Atmaca-Sonmez P, Gurler A. Behçet disease in children. Ocul Immunol Inflamm 2011; 19 (02) 103-107
• 20 Davatchi F, Shahram F, Chams-Davatchi C. , et al. Behcet's disease in Iran: analysis of 6500 cases. Int J Rheum Dis 2010; 13 (04) 367-373
• 21 Houman MH, Bel Feki N. Pathophysiology of Behçet's disease [article in French]. Rev Med Interne 2014; 35 (02) 90-96
• 22 Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?. Rheumatology (Oxford) 2006; 45 (12) 1461-1465
• 23 Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3 (03) 148-155
• 24 Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet's disease. Yonsei Med J 2007; 48 (04) 573-585
• 25 Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol 2017; 35 (05) 421-434
• 26 Karincaoglu Y, Borlu M, Toker SC. , et al. Demographic and clinical properties of juvenile-onset Behçet's disease: a controlled multicenter study. J Am Acad Dermatol 2008; 58 (04) 579-584
• 27 Dalvi SR, Yildirim R, Yazici Y. Behcet's syndrome. Drugs 2012; 72 (17) 2223-2241
• 28 Ahn JK, Lee YS, Jeon CH, Koh EM, Cha HS. Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008; 27 (02) 201-205
• 29 Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017; 377 (12) 1177-1187
• 30 Shimizu T, Ehrlich GE, Inaba G, Hayashi K. Behçet disease (Behçet syndrome). Semin Arthritis Rheum 1979; 8 (04) 223-260
• 31 Akman-Demir G, Serdaroglu P, Tasçi B. ; The Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999; 122 (Pt 11): 2171-2182
• 32 Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet's syndrome. Brain 1999; 122 (Pt 11): 2183-2194
• 33 Landeyro J, Vidaur-Tello L, García-Fontgivell JF, Elguezábal A, Gené-Hijós M, Mayayo-Artal E. [Neuro-Behçet: clinicopathological findings in an autopsy case] (in Spanish). Rev Neurol 2008; 47 (11) 575-578
• 34 Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341 (17) 1284-1291
• 35 Al-Araji A, Kidd DP. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009; 8 (02) 192-204
• 36 Uygunoğlu U, Saip S, Siva A. Behçet's disease and neuro-Behçet's syndrome. EMJ Neurol 2018; 6: 77-85
• 37 Kalra S, Silman A, Akman-Demir G. , et al. Diagnosis and management of neuro-Behçet's disease: international consensus recommendations. J Neurol 2014; 261 (09) 1662-1676
• 38 Deniz O, Cayköylü A, Vural G. , et al. A case study of neuro-psycho-Behçet's syndrome presenting with psychotic attack. Clin Neurol Neurosurg 2009; 111 (10) 877-879
• 39 Yeo M, Lee HL, Cha M. , et al. Neuro-Behcet disease presenting as a solitary cerebellar hemorrhagic lesion: a case report and review of the literature. J Med Case Reports 2016; 10 (01) 360
• 40 Rottenstreich A, Machol K, Eisenstein EM. , et al. Behçet's disease and cerebral sinus vein thrombosis in children: a case study and review of the literature. Clin Exp Rheumatol 2015; 33 (6, Suppl 94): S163-S168
• 41 D’Angelo T, Gallizzi R, Romano C, Cicero G, Mazziotti S. Cicero G, Mazziotti S. Magnetic resonance enterography findings of intestinal Behçet disease in a child. Case Rep Radiol 2017; 2017: 8061648
• 42 Mascalchi M, Cosottini M, Cellerini M, Paganini M, Arnetoli G. MRI of spinal cord involvement in Behçet's disease: case report. Neuroradiology 1998; 40 (04) 255-257
• 43 Coban O, Bahar S, Akman-Demir G, Taşci B, Yurdakul S, Yazici H, Serdaroğlu P. Masked assessment of MRI findings: is it possible to differentiate neuro-Behçet's disease from other central nervous system diseases?. [corrected] Neuroradiology 1999; 41: 255-260
• 44 Wechsler B, Vidailhet M, Piette JC. , et al. Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases. Neurology 1992; 42 (3 Pt 1): 614-618
• 45 Cengiz N, Sahin M, Onar M. Correlation of clinical, MRI and Tc-99m HMPAO SPECT findings in neuro-Behçet's disease. Acta Neurol Belg 2004; 104 (03) 100-105
• 46 Leiba M, Seligsohn U, Sidi Y. , et al. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004; 63 (11) 1445-1449
• 47 Al-Araji A, Sharquie K, Al-Rawi Z. Prevalence and patterns of neurological involvement in Behcet's disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 2003; 74 (05) 608-613
• 48 Boulter E, Brogan P. Behcet's disease. In: Foster H, Brogan P. , eds. Paediatric Rheumatology. Oxford: Oxford University Press; 2012: 205-208
• 49 Ozguler Y, Yazici H. Behçet's syndrome: new insights into pathogenesis and management. Ind Journal of Rheum 2014; 9: 184-191
• 50 Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 2005; 50 (04) 297-350
• 51 Vallet H, Riviere S, Sanna A. , et al; French Behçet Network. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: multicenter study of 124 patients. J Autoimmun 2015; 62: 67-74
• 52 Shapiro LS, Farrell J, Borhani Haghighi A. Tocilizumab treatment for neuro-Behcet's disease, the first report. Clin Neurol Neurosurg 2012; 114 (03) 297-298
• 53 Saadoun D, Wechsler B, Desseaux K. , et al. Mortality in Behçet's disease. Arthritis Rheum 2010; 62 (09) 2806-2812